PAYX
54
3
NEM
61
5
COF
62
2
KMB
53
2
DNB
26
2
CB
53
6
CMS
60
2
PBI
42
3
PEG
48
2
EW
42
2
AMZN
56
-2
SNA
55
2
EXR
35
2
TXN
48
8
BSX
76
7
QCOM
71
3
CTAS
50
-2
WY
45
-2
UPS
46
-2
LRCX
40
-2
PAYX
54
3
NEM
61
5
COF
62
2
KMB
53
2
DNB
26
2
CB
53
6
CMS
60
2
PBI
42
3
PEG
48
2
EW
42
2
AMZN
56
-2
SNA
55
2
EXR
35
2
TXN
48
8
BSX
76
7
QCOM
71
3
CTAS
50
-2
WY
45
-2
UPS
46
-2
LRCX
40
-2
Financhill
Back

Apollo Global Management Vs. Keros Therapeutics Industry Stock Comparison

Buy
70

APO
Apollo Global Management

Last Price:
111.86
Seasonality Move:
8.86%
Sell
22

KROS
Keros Therapeutics

Last Price:
54.22
Seasonality Move:
-16.78%
Buy
70
Apollo Global Management (APO) is a Buy

Is Apollo Global Management a Buy, Sell or Hold?

  • The current Apollo Global Management [APO] share price is $112.72. The Score for APO is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • APO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
22
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $56.24. The Score for KROS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APO Stock Price Chart

What is Apollo Global Management's stock price today?

  • The Apollo Global Management share price today is $112.72
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APO is experiencing selling pressure, which indicates risk of future bearish movement.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $56.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.

APO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 54.77 Buy
Chaikin Money Flow: -735465 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (109.3 - 114.28) Buy
Bollinger Bands (100): (95.44 - 112.16) Buy

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.1 Sell
Relative Strength Index (14 RSI): 37.31 Sell
Chaikin Money Flow: -34931 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.2 - 66) Sell
Bollinger Bands (100): (42.32 - 66.2) Buy

APO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 109.37 Buy
20-day SMA: 111.38 Buy
50-day SMA: 111.23 Buy
200-day SMA: 94.59 Buy
8-day EMA: 110.85 Buy
20-day EMA: 110.92 Buy
50-day EMA: 109.32 Buy
200-day EMA: 95.73 Buy

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.46 Sell
20-day SMA: 60.92 Sell
50-day SMA: 63.51 Sell
200-day SMA: 44.18 Buy
8-day EMA: 57.57 Sell
20-day EMA: 60.06 Sell
50-day EMA: 60.21 Sell
200-day EMA: 49.71 Buy

Apollo Global Management Earnings Growth & APO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.14 per share, an increase this year of $1.12 per share, and an increase next year of $1.31 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.20 per share, an increase this year of $0.03 per share, and a decrease next year of $0.37 per share.

Apollo Global Management Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):